Ferring Pharmaceuticals, Inc.
Monitoring of Safety and Tolerance of PICOPREP in Clinical Practice
- Conditions
- Bowel Cleanliness
- First Posted Date
- 2012-12-12
- Last Posted Date
- 2015-12-22
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 3324
- Registration Number
- NCT01748591
- Locations
- 🇨🇿
Nemocnice Břeclav, Břeclav, Czech Republic
🇨🇿Fakultní nemocnice Hradec Králové, Hradec Králové, Czech Republic
🇨🇿Privátní GE, Jihlava, Czech Republic
One Month Degarelix/Comparator Treatment for Prostate Cancer in Chinese Population
- First Posted Date
- 2012-12-06
- Last Posted Date
- 2015-06-23
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 285
- Registration Number
- NCT01744366
- Locations
- 🇨🇳
Affiliated Southwest Hospital of 3rd Military Medical University of People's Liberation Army, Chongqing, Chongqing, China
🇨🇳2nd.Affiliated Hospital of Xi'an Jiaotong University College of Medicine, Xi'an, Shanxi, China
🇨🇳Cancer Institute & Hospital. Chinese Academy of Medical Sciences, Beijing, Beijing, China
Surveillance of Treatment of Children With Growth Hormone Deficiency With Zomacton®
- First Posted Date
- 2012-11-21
- Last Posted Date
- 2013-02-01
- Lead Sponsor
- Ferring Pharmaceuticals
- Registration Number
- NCT01731028
Impact of the Geographical FACTor on the Prostate Cancer Stage at Hormonal Therapy Initiation
- First Posted Date
- 2012-11-20
- Last Posted Date
- 2014-07-17
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 315
- Registration Number
- NCT01729676
- Locations
- 🇫🇷
Hôpital Robert Boulin, Libourne, France
Interventional Clinical Trial in Patients in Overactive Bladder With Nocturia in Women
- Conditions
- Overactive Bladder
- Interventions
- Drug: Placebo orally disintegrating tablets
- First Posted Date
- 2012-11-20
- Last Posted Date
- 2018-09-12
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 106
- Registration Number
- NCT01729819
- Locations
- 🇺🇸
NEA Baptist Clinic, Jonesboro, Arkansas, United States
🇺🇸Moez Khorsandi, DO, Los Angeles, California, United States
🇺🇸Palm Beach Research Center, West Palm Beach, Florida, United States
Barusiban Subcutaneously for Reducing Implantation Failure Due to Uterine Contractions
- Conditions
- Infertility
- Interventions
- Drug: Placebo Comparator
- First Posted Date
- 2012-11-08
- Last Posted Date
- 2015-06-16
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 256
- Registration Number
- NCT01723982
- Locations
- 🇨🇿
ICF CUBE, Prague, Czech Republic
🇦🇺Westmead Fertility Centre, Westmead, New South Wales, Australia
🇦🇺Monash IVF, Clayton, Victoria, Australia
A Phase III Study of FE 999913 in Japanese Female Patients Undergoing Fertility Treatment
- First Posted Date
- 2012-10-19
- Last Posted Date
- 2014-09-05
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 108
- Registration Number
- NCT01710514
- Locations
- 🇯🇵
Hanabusa Women's Clinic, Kobe, Hyogo, Japan
🇯🇵Ebina Ladies Clinic, Ebina, Kanagawa, Japan
🇯🇵Bashamichi Ladies Clinic, Yokohama, Kanagawa, Japan
A Multicenter Extension Trial to Evaluate the Safety of Testosterone Gel
- First Posted Date
- 2012-10-10
- Last Posted Date
- 2017-10-06
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 145
- Registration Number
- NCT01703741
- Locations
- 🇺🇸
Medical Affiliated Research Center, Huntsville, Alabama, United States
🇺🇸California Professional Research, Newport Beach, California, United States
🇺🇸San Diego Sexual Medicine, San Diego, California, United States
Controlled Ovarian Stimulation by HP-hMG for IVF / ICSI Cycles: Study on Ovarian Hyper Stimulation Syndrome in a Cohort of Women From 18 to 36 Years Old.
- Conditions
- Ovarian Hyperstimulation Syndrome (OHSS)
- Interventions
- Other: Highly purified menotropin (HP- hMG) treatment
- First Posted Date
- 2012-10-10
- Last Posted Date
- 2017-05-31
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 455
- Registration Number
- NCT01703728
- Locations
- 🇫🇷
Cabinet Mirabeau Roy René (there may be other sites in this country), Aix En Provence, France
🇫🇷Hôpital Privé Natecia, Lyon, France
🇫🇷Hôtel Dieu, Angers, France
Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Men
- Conditions
- Nocturia
- Interventions
- Drug: PlaceboDrug: B. Desmopressin 50 µg
- First Posted Date
- 2012-09-27
- Last Posted Date
- 2013-08-23
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 183
- Registration Number
- NCT01694498
- Locations
- 🇯🇵
Harada Urology Clinic, Hyogo, Japan
🇯🇵Yokohama Shinmidori General Hospital, Kanagawa, Japan
🇯🇵Moriguchi Clinic, Tokyo, Japan